Announcing the 2025 OSP Summer Internship
Subscribe to our blog
If you would like to stay up to date with the Office of Science Policy, subscribe to our blog!
Looking for more content? Check out our social media!
Month: January 2025
OSP Now Accepting Applications for 2025 Summer Science Policy Internship Program
What are your plans for the summer? What about spending the summer with NIH shaping biomedical research and building your policy skills? If science policy is your calling, the OSP Summer Internship Program might be right for you.
Hear more about the program from the OSP Director by checking out: https://www.youtube.com/watch?v=1EqhZMhL4PQ and learn how to apply at: https://osp.od.nih.gov/2025internship/. All application materials must be received no later than February 28, 2025.
Questions may be sent to [email protected]. If you are not yet a subscriber to this listserv, please sign up here. You can follow us on X @NIH_OSP as well as LinkedIn.
NIH Issues Agency Implementation Information on U.S. Government Policy for Oversight of Dual Use Research of Concern and Pathogens with Enhanced Pandemic Potential
NIH has issued agency specific information regarding its implementation of the U.S. Government Policy for Oversight of Dual Use Research of Concern and Pathogens with Enhanced Pandemic Potential. The policy, which goes into effect May 6, 2025, is a unified federal oversight framework for conducting and managing certain types of federally funded life sciences research on biological agents and toxins.
The implementation information can be found at: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-25-061.html. NIH will continue to provide updates as additional implementation details are finalized.
Questions may be sent to [email protected]
If you are not yet a subscriber to this listserv, please sign up here. Also, please consider following us on X @NIH_OSP and LinkedIn.
NIH Initiates Access Planning Efforts within Intramural Research Program
NIH is issuing an Intramural Research Program (IRP) policy to promote access to IRP-supported inventions resulting in drugs, biologics, vaccines, or devices. As of June 1, 2025, organizations applying to NIH for certain commercial patent licenses will be required to submit Access Plans to NIH outlining steps they intend to take to promote patient access to those licensed products. NIH will continue working with industry partners to develop additional resources and guidance in support of these efforts.
For more information see https://osp.od.nih.gov/policies/innovation-and-translation#tab1/
Questions may be sent to [email protected]
If you are not yet a subscriber to this listserv, please sign up here. Also, please consider following us on X @NIH_OSP and LinkedIn.